Restful Sleep
Natural health product licensed in Canada
- Other names
- Espira by Avon RE: TUNE RESTFUL SLEEP, Espira by Avon Restful Sleep, RE: TUNE RESTFUL SLEEP
- Licence holder
- The Avon Company Canada Limited
- NPN or DIN-HM
- 80091635
- Status
- Active licence
- Licence date
- 5 April 2019
- Revision date
- 31 August 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 1.5 mg | Not calculated |
| Magnésium Source : Hydroxyde de magnésium | 100 mg | 200,000 µg |
| Magnésium Source : Malate de magnésium | 100 mg | 200,000 µg |
| Magnésium Source : Oxyde de magnésium | 100 mg | 200,000 µg |
| Magnésium Source : Magnesium amino acid chelate | 100 mg | 200,000 µg |
| Matricaria chamomilla Source : Fleur | 50 mg | Not calculated |
| 5-Hydroxy-L-tryptophane Source : Griffonia simplicifolia, graine | 25 mg | Not calculated |
| Passiflora incarnata Source : Fleur Extract : Matériel brut sec Extraction ratio : 4-6:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Humulus lupulus Source : Strobiles Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps in the development and maintenance of bones and teeth. Helps in tissue formation. Helps to maintain proper muscle function. Helps to maintain proper muscle function, including the heart muscle. Source of/An electrolyte for the maintenance of good health. Helps in energy metabolism, tissue formation and bone development. Helps to maintain normal electrolyte balance. Helps to maintain the body's ability to metabolize nutrients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80091635
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging